Aratana Therapeutics - InvestorRoom http://aratana.investorroom.com/ Aratana Therapeutics, Inc. Announces Termination of Offering of Common Stock http://aratana.investorroom.com/2017-11-28-Aratana-Therapeutics-Inc-Announces-Termination-of-Offering-of-Common-Stock Tue, 28 Nov 2017 18:56:00 -0500 http://aratana.investorroom.com/2017-11-28-Aratana-Therapeutics-Inc-Announces-Termination-of-Offering-of-Common-Stock Aratana Therapeutics, Inc. Announces Proposed Public Offering http://aratana.investorroom.com/2017-11-27-Aratana-Therapeutics-Inc-Announces-Proposed-Public-Offering Mon, 27 Nov 2017 16:10:00 -0500 http://aratana.investorroom.com/2017-11-27-Aratana-Therapeutics-Inc-Announces-Proposed-Public-Offering Elanco, Aratana Announce Positive Opinion on GALLIPRANT® (grapiprant tablets) in Europe http://aratana.investorroom.com/2017-11-10-Elanco-Aratana-Announce-Positive-Opinion-on-GALLIPRANT-R-grapiprant-tablets-in-Europe Fri, 10 Nov 2017 11:31:00 -0500 http://aratana.investorroom.com/2017-11-10-Elanco-Aratana-Announce-Positive-Opinion-on-GALLIPRANT-R-grapiprant-tablets-in-Europe Aratana Therapeutics Reports Third Quarter 2017 Financial Results http://aratana.investorroom.com/2017-11-02-Aratana-Therapeutics-Reports-Third-Quarter-2017-Financial-Results Thu, 02 Nov 2017 16:05:00 -0400 http://aratana.investorroom.com/2017-11-02-Aratana-Therapeutics-Reports-Third-Quarter-2017-Financial-Results Aratana Therapeutics to Present at Credit Suisse Healthcare Conference http://aratana.investorroom.com/2017-10-30-Aratana-Therapeutics-to-Present-at-Credit-Suisse-Healthcare-Conference Mon, 30 Oct 2017 08:30:00 -0400 http://aratana.investorroom.com/2017-10-30-Aratana-Therapeutics-to-Present-at-Credit-Suisse-Healthcare-Conference